Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients
Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients
Not yet recruiting · NCT07559032 · Registry updated 2026-04-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients | Bacterial Infections and Mycoses, Hemic and Lymphatic Diseases, Infections, Invasive Fungal Infections, fungal infectious disease, hematologic disorder | Not yet recruiting | Not applicable | 2026-04-30 | NCT07559032 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University People's Hospital | Beijing | China | 44 |